PGNY Q2 2024 Earnings — Progyny, Inc. Revenue & Financial Results | Market Cap Arena

PGNYProgyny, Inc.

$1B

Q2 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$304M+8.8% YoY

Gross Profit

$68M22.5% margin

Operating Income

$21M6.8% margin

Net Income

$16M5.4% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

+9.4%

Cash Flow

Operating Cash Flow

$57M

Free Cash Flow

$56M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$699M

Total Liabilities

$242M

Stockholders' Equity

$456M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$304M	$279M	+8.8%
Gross Profit	$68M	$61M	+12.6%
Operating Income	$21M	$15M	+36.2%
Net Income	$16M	$15M	+10.0%

Revenue Segments

Fertility benefit services revenue

$194M64%

Pharmacy benefit services revenue

$111M36%